Manns M, Bergquist A, Karlsen T, Levy C, Muir A, Ponsioen C
Nat Rev Dis Primers. 2025; 11(1):17.
PMID: 40082445
DOI: 10.1038/s41572-025-00600-x.
Villard C, Jorns C, Bergquist A
eGastroenterology. 2025; 2(1):e100045.
PMID: 39944751
PMC: 11770459.
DOI: 10.1136/egastro-2023-100045.
Cancado G, Hirschfield G
Hepatol Commun. 2025; 8(12).
PMID: 39774274
PMC: 11567710.
DOI: 10.1097/HC9.0000000000000590.
Wu N, Bayatpour S, Hylemon P, Aseem S, Aseem S, Brindley P
Am J Pathol. 2024; 195(3):397-408.
PMID: 39730075
PMC: 11841492.
DOI: 10.1016/j.ajpath.2024.11.004.
Crothers H, Ferguson J, Quraishi M, Cooney R, Iqbal T, Trivedi P
Lancet Reg Health Eur. 2024; 44:101002.
PMID: 39099647
PMC: 11296053.
DOI: 10.1016/j.lanepe.2024.101002.
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
Tan N, Ngu N, Worland T, Lee T, Abrahams T, Freeman E
Hepatol Commun. 2024; 8(5).
PMID: 38696372
PMC: 11068143.
DOI: 10.1097/HC9.0000000000000442.
An overview of recent treatment options for primary sclerosing cholangitis.
Mousavere I, Kalampokis G, Fousekis F, Karayiannis P, Baltayiannis G, Christodoulou D
Ann Gastroenterol. 2023; 36(6):589-598.
PMID: 38023975
PMC: 10662072.
DOI: 10.20524/aog.2023.0834.
In a tight spot.
Przybyszewski E, Pratt D
Clin Liver Dis (Hoboken). 2023; 21(3):69-72.
PMID: 37937257
PMC: 10627587.
DOI: 10.1097/CLD.0000000000000020.
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.
Catanzaro E, Gringeri E, Burra P, Gambato M
Cancers (Basel). 2023; 15(20).
PMID: 37894314
PMC: 10604939.
DOI: 10.3390/cancers15204947.
Advances in the Early Detection of Hepatobiliary Cancers.
Yildirim H, Kavgaci G, Chalabiyev E, Dizdar O
Cancers (Basel). 2023; 15(15).
PMID: 37568696
PMC: 10416925.
DOI: 10.3390/cancers15153880.
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
Kim Y, Hurley E, Park Y, Ko S
Exp Mol Med. 2023; 55(7):1380-1387.
PMID: 37464092
PMC: 10394020.
DOI: 10.1038/s12276-023-01042-9.
The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
Wentworth B, Khot R, Caldwell S
Dig Dis Sci. 2023; 68(9):3514-3526.
PMID: 37358638
DOI: 10.1007/s10620-023-08003-2.
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.
Eder P, Lodyga M, Gawron-Kiszka M, Dobrowolska A, Gonciarz M, Hartleb M
Prz Gastroenterol. 2023; 18(1):1-42.
PMID: 37007752
PMC: 10050986.
DOI: 10.5114/pg.2023.125882.
Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?.
Gleeson D, Walmsley M, Trivedi P, Joshi D, Rea B
Frontline Gastroenterol. 2023; 14(2):162-166.
PMID: 36818795
PMC: 9933607.
DOI: 10.1136/flgastro-2022-102172.
Primary sclerosing cholangitis: review for radiologists.
Morgan M, Khot R, Sundaram K, Ludwig D, Nair R, Mittal P
Abdom Radiol (NY). 2022; 48(1):136-150.
PMID: 36063181
PMC: 9852001.
DOI: 10.1007/s00261-022-03655-6.
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.
Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N
Liver Cancer. 2022; 11(4):290-314.
PMID: 35978598
PMC: 9294959.
DOI: 10.1159/000522403.
Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Bergquist A, Weismuller T, Levy C, Rupp C, Joshi D, Nayagam J
Liver Int. 2022; 43(1):127-138.
PMID: 35535655
PMC: 10084018.
DOI: 10.1111/liv.15286.
Risk of Hepatobiliary-Gastrointestinal Malignancies and Appropriate Cancer Surveillance in Patients With Primary Sclerosing Cholangitis.
Yadlapati S, Judge T
Cureus. 2022; 13(11):e19922.
PMID: 34976523
PMC: 8712253.
DOI: 10.7759/cureus.19922.
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Saffioti F, Mavroeidis V
World J Gastrointest Oncol. 2021; 13(10):1336-1366.
PMID: 34721770
PMC: 8529934.
DOI: 10.4251/wjgo.v13.i10.1336.
Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
Bosch D, Zen Y, Boukhar S, Liu Y, Cheng L, Yeh M
Virchows Arch. 2021; 479(6):1131-1143.
PMID: 34414507
DOI: 10.1007/s00428-021-03183-6.